Human Oxysterols receptor LXR-alpha Antibody from MYBIOSOURCE INC.
Search, find, compare suppliers for anti-Human Oxysterols receptor LXR-alpha antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | Human Oxysterols receptor LXR-alpha |
| Clone | polyclonal |
| Host Species | Rabbit |
| Reactive Species | human |
| Isotype | n/a |
| Format | biotin conjugate |
| Size | 0.05 mg, 0.1 mg |
| Concentration | n/a |
| Applications | ELISA (EIA) |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | Nuclear receptor. Interaction with RXR shifts RXR from its role as a silent DNA-binding partner to an active ligand-binding subunit in mediating retinoid responses through target genes defined by LXRES. LXRES are DR4-type response elements characterized by direct repeats of two similar hexanuclotide half-sites spaced by four nucleotides. Plays an important role in the regulation of cholesterol homeostasis, regulating cholesterol uptake through MYLIP-dependent ubiquitination of LDLR, VLDLR and LRP8. Interplays functionally with RORA for the regulation of genes involved in liver metabolism. |
| Immunogen | Immunogen: Recombinant human Oxysterols receptor LXR-alpha protein Santa Cruz Alternative: Potential replacement for Santa Cruz Biotechnology antibody catalog# sc-34386 / sc-1202 |
| Other Names | [Liver X receptor alpha; Nuclear receptor subfamily 1 group H member 3; NR1H3], [NR1H3; NR1H3; LXRA; LXR-a; RLD-1; LXRA] |
| Gene, Accession # | [LXRA], Gene ID: 10062, NCBI: NP_001123573.1, UniProt: Q13133 |
| Catalog # | MBS1488370 |
| Price | $160, $235 |
| Order / More Info | Human Oxysterols receptor LXR-alpha Antibody from MYBIOSOURCE INC. |
| Product Specific References | n/a |
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166
sales@mybiosource.com
http://www.MyBioSource.com
Profile of MYBIOSOURCE INC.
Return to Antibodies